| Digestive System Neuroendocrine Neoplasm studied in …STUDIED_INderived200 of 295show all (up to 200) |
|---|
| → studied in | NCT01824875Phase 2 · completed Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Gastrin-Producing Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Bladder Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06479811Phase 1 · recruiting [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06943755Phase 2/Phase 3 · recruiting Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001276recruiting Diagnosing and Treating Low Blood Sugar Levels · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05196087recruiting Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!) · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04924075Phase 2 · recruiting Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015) · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07842172Phase 3 · not yet recruiting Somatostatin Analogues vs. Observation After Peptide Receptor Radionuclide Therapy (PRRT) in Nonfunctional Neuroendocrine Neoplasms · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05773274Phase 2 · recruiting Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial · condition mapped CURATED_BROADER · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03967951completed CT Radiomic Features of Pancreatic Neuroendocrine Neoplasms · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03375320Phase 3 · active not recruiting Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors · condition mapped CURATED_BROADER · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03950609Phase 2 · active not recruiting Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04234568Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors · condition mapped CURATED_BROADER · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07817225active not recruiting Optimizing Risk Assessment Through cfDNA in Pancreatic Neuroendocrine Tumors for Clinical Evaluation · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07087054Phase 3 · recruiting Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Serotonin-Producing Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07165132Phase 1 · recruiting Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06784752Phase 3 · recruiting Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Bladder Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07808879NA · recruiting Comparison of [68Ga]Ga-HBED-CC-PEG6-Exendin-4 and [68Ga]Ga-HBED-CC-Exendin-4 PET/CT for Insulinoma Localization · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06725693recruiting Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05687123Phase 1 · recruiting Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors · condition mapped CURATED_BROADER · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05247905Phase 2 · active not recruiting Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET Trial · condition mapped CURATED_BROADER · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00569127Phase 3 · active not recruiting Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Colorectal Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01841736Phase 2 · active not recruiting Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Foregut Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05997056Phase 2 · completed Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05064150active not recruiting Neuroendocrine Tumors - Patient Reported Outcomes · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06202066Phase 2 · suspended Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07274657NA · recruiting Superb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) in Differential Diagnosis of Pancreatic Adenocarcinoma (PA) From Other Pancreatic Solid Lesions (PSLs) and Pancreatic neuroendocrinE Tumors (pNETs) Malignancy · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06427798Phase 1/Phase 2 · recruiting Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07620574Phase 3 · enrolling by invitation Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04609592Phase 1 · active not recruiting Study of PRRT in Metastatic, WHO Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07759960NA · recruiting Underwater Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Small Rectal Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Rectal Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04993261early Phase 1 · active not recruiting An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05262556Phase 1 · completed NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595424Phase 2 · active not recruiting Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Gastric Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07728292NA · recruiting Safety and Efficacy of Underwater Endoscopic Mucosal Resection for Type I Gastric Neuroendocrine Tumors Measuring 5-9 mm · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Gastric Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01365169NA · recruiting Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06876532NA · recruiting Evaluation of the Inflammation-based Index as a Predictive Marker of Clinical and Radiological Response in Patients Treated With Lu-177 Oxodotreotide for Intestinal Neuroendocrine Tumour · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Intestinal Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07695532completed A Clinical Risk Score to Stratify High-risk PanNETs · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00113360Phase 2 · completed RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07635316recruiting A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06790706Phase 2 · active not recruiting IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06016855Phase 4 · recruiting Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors · condition mapped CURATED_BROADER · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07661420Phase 1 · not yet recruiting 211At-MABG in Adults With Advanced Neuroendocrine Cancers · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Anal Canal Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06091748Phase 3 · completed Gallium (68Ga) Edotreotide PET/CT for Imaging Patients With Gastrointestinal Pancreatic Neuroendocrine Tumors · condition mapped CURATED_BROADER · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06158516Phase 2 · terminated A Study of Surufatinib as Adjuvant Therapy for Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07612748NA · recruiting Two Different Endoscopic Treatments for Rectal Neuroendocrine Neoplasms · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Rectal Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07619417NA · not yet recruiting Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic Neoplasms · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05884255Phase 3 · recruiting An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors. · condition mapped CURATED_BROADER · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07591493Phase 3 · not yet recruiting Adjuvant Trial in Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05636618Phase 1/Phase 2 · recruiting Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05988918Phase 2 · active not recruiting Multicenter Trial of ESK981 in Patients With Select Solid Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03583528active not recruiting DOTATOC PET/CT for Imaging NET Patients · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07554560NA · recruiting Nutrition Intervention for Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04727723completed Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in GEP-NETs · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01916148available 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07165886Phase 2/Phase 3 · recruiting Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07536087NA · recruiting Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05048901Phase 1/Phase 2 · recruiting Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06141369NA · recruiting Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05477576Phase 3 · recruiting Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05847855recruiting Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04090034recruiting Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05361668Phase 2 · completed Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Serotonin-Producing Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05411133Phase 1 · completed Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04119024Phase 1 · recruiting Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00830557recruiting Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07150546Phase 1 · recruiting Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors. · condition mapped CURATED_BROADER · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07439757recruiting AI-Powered Precision Decision-Making for Pancreatic Diseases · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04907643NA · recruiting Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Serotonin-Producing Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07410767not yet recruiting Advanced Endoscopic Resections for Rectal Neoplasms · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Rectal Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04711135Phase 2 · active not recruiting Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03879694Phase 1 · completed Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors · condition mapped CURATED_BROADER · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07373015NA · not yet recruiting Modified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Rectal Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05746182recruiting Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07273409NA · recruiting Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04505553Phase 2 · completed Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07328607NA · recruiting Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06356467recruiting Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07340437completed Clinical Study of 18F-Exendin-4 in Insulinoma · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03891784Phase 2 · active not recruiting Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors · condition mapped CURATED_BROADER · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05987176Phase 2 · terminated Comparison of Adjuvant Treatment With 177Lu-DOTATATE to Best Supportive Care in Patients After Resection of Neuroendocrine Liver Metastases · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05735912NA · active not recruiting EUS-RFA Versus Surgery for Pancreatic Insulinoma (ERASIN-RCT) · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06406387active not recruiting ATRX/DAXX in EUS-FNB Specimens of Pan-NETs · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06663072Phase 1 · recruiting Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors · condition mapped CURATED_BROADER · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07302100recruiting Nutritional Status Assessment in Adult Patients Followed for Gastroenteropancreatic Neuroendocrine Tumors at Strasbourg University Hospital · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03600233Phase 2 · active not recruiting Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05040360Phase 2 · recruiting Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05364944Phase 1 · terminated A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03582475Phase 1 · active not recruiting Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Bladder Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02159989Phase 1 · completed Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07121478Phase 2 · enrolling by invitation Patients With High-grade Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07188441Phase 2 · recruiting Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With Cisplatin. · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06256705NA · recruiting Multi-modal Characterisation of Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05385861Phase 1/Phase 2 · enrolling by invitation Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541652recruiting A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Liver Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04579679Phase 2 · terminated Open-Label Surufatinib in European Patients With NET · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Small Intestinal Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05173246Phase 2 · recruiting JS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal Carcinoma · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Esophageal Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02611024Phase 1/Phase 2 · completed Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04735198NA · recruiting Prophylactic Cholecystectomy in Midgut NETs Patients Who Require Primary Tumor Surgery. · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Midgut Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06121622recruiting Development of New Personalised 3D Preclinical Models of Pancreatic Neuroendocrine Tumours · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02230176Phase 2 · completed Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05734430recruiting Genetics of Appendix Cancer Study · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Appendix Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03667092NA · completed Exploration of Molecular Biomarkers for Lu-177 DOTATATE Therapy in Midgut Neuroendocrine Tumor · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Midgut Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06901856NA · not yet recruiting Endoscopic Resection for Small Rectal Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Rectal Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04986085completed Nutrition in Gastroenteropancreatic Neuroendocrine Tumor · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05246319completed Preoperative Imaging in Patients With Small Bowel Neuroendocrine Tumors · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Small Intestinal Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02842749Phase 4 · completed Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04197310Phase 2 · completed Cabozantinib and Nivolumab for Carcinoid Tumors · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03736720Phase 2 · terminated Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin · condition mapped CURATED_BROADER · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04524442Phase 4 · completed Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06790056completed Efficacy of Endoscopic Band Ligation (DEBL) for Duodenal Neuroendocrine Neoplasms(dNENs) · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Duodenal Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03980925Phase 2 · completed Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin. · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06592989recruiting A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02185443Phase 2 · recruiting Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06663852completed ML Decision Model for G-NEC Adjuvant Therapy · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Gastric Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05568017Phase 2 · terminated Neoadjuvant PRRT With Y-90-DOTATOC in pNET · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06024343NA · completed Minimally Invasive Pancreatic Enucleation With Main Pancreatic Duct Exposure, Repair or Reconstruction · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06557408completed Pancreatic Fistula After Minimally Invasive Enucleation · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05610826Phase 1/Phase 2 · withdrawn Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the Liver · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06041009recruiting Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04852679Phase 3 · completed Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETs · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05176665Phase 1/Phase 2 · unknown EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers · condition mapped CURATED_BROADER · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00655655Phase 1 · completed Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Gastrin-Producing Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04931420Phase 2 · withdrawn Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Foregut Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02021604Phase 1 · recruiting Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02110563Phase 1 · terminated Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06478264Phase 2 · not yet recruiting A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Esophageal Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02282059completed The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05701241Phase 4 · recruiting Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06246630NA · unknown In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor · condition mapped CURATED_BROADER · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06402695unknown Observational Study on GEP-and Pulm-NET Treated at FPG · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00970970completed Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05359146early Phase 1 · unknown Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3) · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05476978completed Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01466036Phase 2 · completed Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06279299NA · recruiting Lateral Pelvic Lymph Node Dissection for Rectal Neuroendocrine Neoplasms Undergoing Laparoscopic Total Mesenteric Excision · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Rectal Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01525082Phase 2 · completed Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Gastrin-Producing Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03084770unknown Asymptomatic Small Pancreatic Endocrine Neoplasms. · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Non-Functioning Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06155318recruiting 68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04452396NA · terminated CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06167421NA · not yet recruiting Comparison of Kimura Versus Warshaw Technique for Laparoscopic Spleen-Preserving Distal Pancreatectomy · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05709171Phase 2 · unknown Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04602117Phase 1 · withdrawn ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer · condition mapped CURATED_BROADER · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02264665completed OPALINE : A Study Of Morbidity And Mortality At 2 Years · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05523778NA · unknown A Multi-center Study to Evaluate the Efficacy and Safety of Pancreatic Duct Stents Placement Before the Enucleation of Insulinoma Located in the Head and Neck of the Pancreas Near the Main Pancreatic Duct · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06102746unknown Clinical Study of Surufatinib Plus Sintilimab Combined With Chemotherapy in the Treatment of Advanced Gastric Neuroendocrine Carcinoma · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Gastric Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06080204NA · completed Real-world Study on Adjuvant Octreotide Therapy in pNETs · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor G2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02893930Phase 2 · completed Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06070740Phase 2 · recruiting First- Line Treatment With Durvalumab Plus XELOX Chemotherapy in Advanced Gastrointestinal Neuroendocrine Carcinoma · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05448157unknown 68Ga-DOTATOC Radio-Guided Surgery With β-Probe in GEP-NET · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04979611Phase 1 · unknown The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05907824unknown Long-term Prognosis for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cm · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Non-Functioning Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00427349Phase 2 · completed AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02031536Phase 2 · terminated Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Gastrin-Producing Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03043664Phase 1/Phase 2 · completed Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05582031Phase 2 · withdrawn Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05171517completed Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00227617Phase 2/Phase 3 · terminated Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05800106Phase 1 · completed A Bioequivalence Study of Sunitinib Malate Capsules. · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05243082NA · recruiting Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03918759completed Diagnostic Accuracy of Preoperative Diagnostic Procedure in the Assessment of Lymph Node Metastases by NF-PanNENs · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Non-Functioning Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02431715no longer available 18F-FDOPA PET in Neuroendocrine Tumours · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04915144Phase 2 · withdrawn 177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05671393completed the Optimal Surveillance Frequency for Patients With Gastric Neuroendocrine Carcinoma · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Gastric Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01842165Phase 3 · completed 177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETs · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00396279Phase 2 · completed Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03722511Phase 2 · completed Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02608203Phase 2/Phase 3 · completed [68 Ga]-DOTANOC PET/CT in GEP-NETs · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05034783early Phase 1 · unknown [68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05566093NA · unknown EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Non-Functioning Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02651987Phase 2 · completed Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Midgut Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05554744NA · unknown EUS-FNI for MEN1-related Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04483349completed Assessment of What Patients and Healthcare Providers Value · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01229943Phase 2 · completed Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02358356Phase 2 · completed Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Midgut Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05429216NA · not yet recruiting Endoscopic Resection for Small Rectal Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Rectal Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03741517unknown Biomarker Study of Pancreatic Neuroendocrine Tumours · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02586844completed Prospective Comprehensive Molecular Profiling In Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05316480Phase 2 · not yet recruiting Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03147768Phase 1 · completed Laser Tissue Welding - Distal Pancreatectomy Sealing Study · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01747096NA · completed TEP With 68-DOTANOC in Gastroenteropancreatic Neuroendocrine Tumors · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02259725Phase 2 · completed Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Gastrin-Producing Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02630654completed Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869725Phase 2 · completed Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Somatostatin-Producing Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01465659Phase 1/Phase 2 · completed Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Malignant Pancreatic Glucagonoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02948946completed Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03189953Phase 1/Phase 2 · completed 68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03947762terminated Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice. · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03053284Phase 2 · withdrawn Pasireotide in Hyperinsulinemic Hypoglycemia · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03042780Phase 2 · terminated FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04634448NA · not yet recruiting The Prevalence of Appendiceal Tumours in Periappendicular Abscess · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Appendix Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02853422completed Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02420691Phase 2 · completed Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin · condition mapped CURATED_BROADER · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02355535Phase 1 · completed Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1 · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02575300Phase 2 · completed Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00576680Phase 1/Phase 2 · completed RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 295 trials mapped (98 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02730104completed Community-based Neuroendocrine Tumor (NET) Research Study · condition mapped ALIAS · 295 trials mapped (98 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |